Drag a card by its title · ⚙ to size, swap or remove

The company

Fennec Pharmaceuticals Inc.

FENC · Nasdaq

Health CareBiotechnologyLeading

FENC stood above a rising 150-day average in 22 of the last 52 weekly readings, including each of the last 20 weeks. It is 5.7% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Leading
Weeks in an uptrend: 20 in a row
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $13.9M
Officials’ trades on record: 0
Institutions holding: 103 (+17)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 22 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months19

Buyers · sellers0 · 8

Who	Did	Shares	Traded
Marco Maria BrugheraDirector	sold	15,545at $10.29	15 Sep 2026filed 16 Sep 2026
Rosty RaykovOther	sold	10,000at $12.11	1 Sep 2026filed 1 Sep 2026
Pierre Sargis SayadChief Medical Officer	sold	12,000at $12.18	31 Aug 2026filed 31 Aug 2026
Robert AndradeCHIEF FINANCIAL OFFICER	sold	75,000at $11.78	27 Aug 2026filed 28 Aug 2026
Rosty RaykovOther	sold	10,000at $9.58	3 Aug 2026filed 4 Aug 2026
Rosty RaykovOther	sold	9,599at $10.41	1 Jul 2026filed 2 Jul 2026
Rosty RaykovDirector	sold	9,747at $9.62	1 Jun 2026filed 2 Jun 2026
Chris A. RallisDirector	sold	8,346at $7.04	11 May 2026filed 12 May 2026
Rosty RaykovDirector	sold	10,781at $6.47	1 May 2026filed 1 May 2026
Rosty RaykovDirector	sold	10,946at $6.31	1 Apr 2026filed 2 Apr 2026
Rosty RaykovDirector	sold	10,079at $8.36	2 Mar 2026filed 3 Mar 2026
Rosty RaykovDirector	sold	10,349at $7.76	2 Feb 2026filed 2 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders103+17 on the quarter

New · exited28 · 10

Reported value$174.9M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Rosalind Advisors, Inc.added · filed 14 Aug 2026	3,188,001$34.3M	+279,800+9.6%
AIGH Capital Management LLCadded · filed 7 Aug 2026	2,486,038$26.7M	+504,537+25.5%
Solas Capital Management, LLCreduced · filed 14 Aug 2026	1,889,366$20.3M	-592,832−23.9%
BlackRock, Inc.added · filed 7 Aug 2026	1,727,069$18.6M	+358,893+26.2%
AWM Investment Company, Inc.added · filed 14 Aug 2026	1,160,296$12.5M	+440,161+61.1%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026	839,306$9.0M	-57,838−6.4%
Prospect Capital Advisors, LLCnew · filed 14 Aug 2026	497,800$5.4M	+497,800
STATE STREET CORPadded · filed 7 Aug 2026	426,004$4.6M	+66,949+18.6%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	402,566$4.3M	+30,828+8.3%
JANE STREET GROUP, LLCnew · filed 14 Aug 2026	233,877$2.5M	+233,877